Dr. Shay Wolfling

Biography

Dr. Shay Wolfling joined Nova in 2011 as the Company’s Chief Technology Officer.  Prior to joining Nova, Dr. Wolfling was an R&D manager at KLA-Tencor-Belgium (formerly ICOS Vision Systems, a publicly traded company acquired by KLA in 2008), where he led multidisciplinary metrology & inspection development projects. Previously Dr. Wolfling was a founder and VP R&D of Nano-Or-Technologies, a start-up company with a proprietary technology for 3D optical measurements, which was acquired by ICOS Vision Systems in 2005. He took Nano-Or from the idea stage to initial product sales. Prior to founding Nano-Or, Shay was a project manager in Y-beam, a start-up offering laser-based skin treatments. Dr. Wolfling has authored several patents in the field of optical measurements. He holds a B.Sc. in physics and mathematics from the Hebrew University of Jerusalem, a M.Sc in physics from Tel-Aviv University, and a PhD in physics from the Hebrew University of Jerusalem.

Research Interest

Dr. Shay Wolfling joined Nova in 2011 as the Company’s Chief Technology Officer.  Prior to joining Nova, Dr. Wolfling was an R&D manager at KLA-Tencor-Belgium (formerly ICOS Vision Systems, a publicly traded company acquired by KLA in 2008), where he led multidisciplinary metrology & inspection development projects. Previously Dr. Wolfling was a founder and VP R&D of Nano-Or-Technologies, a start-up company with a proprietary technology for 3D optical measurements, which was acquired by ICOS Vision Systems in 2005. He took Nano-Or from the idea stage to initial product sales. Prior to founding Nano-Or, Shay was a project manager in Y-beam, a start-up offering laser-based skin treatments.